- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.04. | FDA seeks permanent future for rare pediatric priority review vouchers | ||
| 09.04. | Shionogi secures $482m BARDA contract to tackle AMR crisis | ||
| 09.04. | Jeito Capital secures over $1.2bn for new biopharma investments | ||
| 08.04. | Sidewinder pockets $137m in Series B to take bispecific ADCs to clinic | ||
| 08.04. | RoosterBio and MineBio team up to expand MSC solutions access in China | ||
| 08.04. | Pharma industry laments Trump's tariff on branded drugs | ||
| 08.04. | Halozyme and Vertex sign deal for Hypercon technology | ||
| 07.04. | Gilead outlays $5bn to acquire ADC specialist Tubulis | ||
| 07.04. | Apnimed obtains up to $150m in funds for commercial launch of AD109 | ||
| 07.04. | Neurocrine to acquire Soleno in $2.9bn transaction | ||
| 06.04. | Aspect Biosystems receives funding for cellular medicine project | ||
| 06.04. | MSD secures EC clearance for Keytruda combination therapy for ovarian cancer | ||
| 02.04. | Eli Lilly wins FDA approval for weight loss pill, tees up Novo rivalry | ||
| 02.04. | Merck KGaA acquires JSR chromatography business | ||
| 02.04. | Biocytogen and Sihuan partner to advance new therapeutics for weight loss | ||
| 01.04. | Eli Lilly outlays $7.8bn to acquire sleep drug biotech Centessa | ||
| 01.04. | Biogen uplifts rare disease pipeline with $5.6bn Apellis buyout | ||
| 01.04. | Eli Lilly outlays $7.3bn to acquire sleep drug biotech Centessa | ||
| 01.04. | Telomir seeks FDA approval for Telomir-1 to treat breast cancer | ||
| 01.04. | Symeres and Ambagon collaborate for colorectal cancer molecules | ||
| 31.03. | Teva receives FDA approval for Prolia biosimilar | ||
| 31.03. | Blackstone closes largest ever private funding investment round at $6.3bn | ||
| 31.03. | uBriGene and Cellinfinity BIO collaborate to accelerate in vivo CAR-T therapies | ||
| 30.03. | Otsuka agrees to acquire Transcend Therapeutics for $1.22bn | ||
| 30.03. | Eli Lilly and Insilico Medicine forge $2.75bn AI-driven R&D pact |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.